- Home
- MBRX vs SYRA Comparison
MBRX vs SYRA Comparison
Compare MBRX & SYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBRX
- SYRA
- Stock Information
- Founded
- MBRX 2015
- SYRA 2020
- Country
- MBRX United States
- SYRA United States
- Employees
- MBRX N/A
- SYRA N/A
- Industry
- MBRX Biotechnology: Pharmaceutical Preparations
- SYRA Other Specialty Stores
- Sector
- MBRX Health Care
- SYRA Industrials
- Exchange
- MBRX Nasdaq
- SYRA Nasdaq
- Market Cap
- MBRX 6.6M
- SYRA 7.8M
- IPO Year
- MBRX 2016
- SYRA 2023
- Fundamental
- Price
- MBRX $2.37
- SYRA $0.40
- Analyst Decision
- MBRX Strong Buy
- SYRA
- Analyst Count
- MBRX 3
- SYRA 0
- Target Price
- MBRX $35.00
- SYRA N/A
- AVG Volume (30 Days)
- MBRX 47.4K
- SYRA 110.4K
- Earning Date
- MBRX 11-11-2024
- SYRA 11-12-2024
- Dividend Yield
- MBRX N/A
- SYRA N/A
- EPS Growth
- MBRX N/A
- SYRA N/A
- EPS
- MBRX N/A
- SYRA N/A
- Revenue
- MBRX N/A
- SYRA $7,069,566.00
- Revenue This Year
- MBRX N/A
- SYRA $42.88
- Revenue Next Year
- MBRX N/A
- SYRA N/A
- P/E Ratio
- MBRX N/A
- SYRA N/A
- Revenue Growth
- MBRX N/A
- SYRA 25.18
- 52 Week Low
- MBRX $0.40
- SYRA $0.34
- 52 Week High
- MBRX $6.24
- SYRA $8.37
- Technical
- Relative Strength Index (RSI)
- MBRX 44.84
- SYRA 34.69
- Support Level
- MBRX $2.30
- SYRA $0.35
- Resistance Level
- MBRX $2.63
- SYRA $0.42
- Average True Range (ATR)
- MBRX 0.18
- SYRA 0.03
- MACD
- MBRX -0.01
- SYRA 0.03
- Stochastic Oscillator
- MBRX 12.96
- SYRA 55.28
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
About SYRA Syra Health Corp.
Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health.